Multiple spinal muscular atrophy disease-modifying effects of a Hspa8G470R synaptic chaperone variant
Clicks: 2
ID: 318727
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
2 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #368 of 375 articles by views in Brain research
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 375 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Spinal muscular atrophy (SMA) is an oft-fatal infantile-onset neuromuscular disease caused by homozygous loss of the Survival of Motor Neuron 1 (SMN1) gene and, consequently, low SMN protein. Administration of SMN-inducing agents to SMA newborns prevents early mortality, but therapeutic outcomes vary considerably, and disease mechanisms remain poorly understood. Genetic modifiers can provide clues to disease mechanisms and serve as targets for novel treatments. Here, we describe how one such modifier, an Hspa8G470R synaptic chaperone variant we identified, suppresses SMA in model mice. Our results highlight two distinct mechanisms of action of the variant chaperone. First, it raises SMN incrementally, an outcome we discovered is not linked to a previously identified splice modulating function of the modifier but instead to Hspa8G470R-mediated autophagy, effects of the variant on autophagy-associated intermediate complexes and, ultimately, reduced SMN turnover. Interestingly, however, the modifier also stimulated neuromuscular transmission significantly, raising the effective, functional readily releasable pool of motor neuronal synaptic vesicles. Notably, this second outcome was not limited to mutants alone but discernible in healthy controls too, appearing independent of SMN levels and thus indicative of a distinct disease-modifying effect of the chaperone variant that operates specifically at neuromuscular synapses. Combined, the two mechanisms of Hspa8G470R action identified here suppressed the SMA phenotype potently, preventing spinal motor neuron degeneration, ameliorating neuromuscular dysfunction and extending lifespan in model mice more than ten-fold. Results presented in this study shed additional light on pathways gone awry in SMA - ones that might be modulated to develop or refine therapies for neuromuscular disorders at large.
| Reference Key |
openalex_W7165916828
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Yoon-Ra Her, Andrea Fuentes, Rashmi Kothary, Lucı́a Tabares, Umrao R. Monani |
| Journal | Brain research |
| Year | 2026 |
| DOI |
10.1093/brain/awag224
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.